Published in Br J Dermatol on January 09, 2012
Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis. ScientificWorldJournal (2014) 1.00
Evaluation of Perifollicular Inflammation of Donor Area during Hair Transplantation in Androgenetic Alopecia and its Comparison with Controls. Int J Trichology (2013) 0.75
Lichen Planopilaris in the Androgenetic Alopecia Area: A Pitfall for Hair Transplantation. Skin Appendage Disord (2015) 0.75
A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol (2001) 6.12
Sonic hedgehog signaling is essential for hair development. Curr Biol (1998) 5.58
Controls of hair follicle cycling. Physiol Rev (2001) 5.49
British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009. Br J Dermatol (2009) 4.12
Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood (1999) 3.53
British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. Br J Dermatol (2005) 3.10
Noggin is a mesenchymally derived stimulator of hair-follicle induction. Nat Cell Biol (1999) 2.99
Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98
Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis (2005) 2.61
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut (2005) 2.36
Taxane-induced nail changes: incidence, clinical presentation and outcome. Ann Oncol (2003) 2.35
Effects of a cosmetic 'anti-ageing' product improves photoaged skin [corrected]. Br J Dermatol (2009) 2.25
Interleukin-15 protects from lethal apoptosis in vivo. Nat Med (1997) 2.22
Hair diameter diversity: a clinical sign reflecting the follicle miniaturization. Arch Dermatol (2001) 2.16
Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. FASEB J (2000) 2.09
Noggin is required for induction of the hair follicle growth phase in postnatal skin. FASEB J (2001) 1.95
Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J Invest Dermatol (1993) 1.88
Analysis of apoptosis during hair follicle regression (catagen) Am J Pathol (1997) 1.82
Graying: gerontobiology of the hair follicle pigmentary unit. Exp Gerontol (2001) 1.75
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction. Br J Dermatol (2005) 1.72
Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood (1999) 1.71
Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. Br J Dermatol (2005) 1.67
What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65
Monitoring levels of preservative sensitivity in Europe. A 10-year overview (1991-2000). Contact Dermatitis (2002) 1.63
Retracted Death deflected: IL-15 inhibits TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chain. FASEB J (1999) 1.60
Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res (2010) 1.60
Audiologic abnormalities in cases of vitiligo. J Am Acad Dermatol (1987) 1.59
Tumour necrosis factor-alpha-induced migration of human Langerhans cells: the influence of ageing. Br J Dermatol (2002) 1.59
Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med (1993) 1.58
Melanocytes as "sensory" and regulatory cells in the epidermis. J Theor Biol (1993) 1.55
Nail changes in lichen planus may resemble those of yellow nail syndrome. Br J Dermatol (2000) 1.50
Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases. Br J Dermatol (2005) 1.49
Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo. FASEB J (2000) 1.48
Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. Ann Rheum Dis (2007) 1.47
Multiple keratoacanthoma in discoid lupus erythematosus. J Am Acad Dermatol (1989) 1.46
Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. J Med Genet (2007) 1.44
Onycholysis and subungual haemorrhages secondary to systemic chemotherapy (paclitaxel). J Eur Acad Dermatol Venereol (2003) 1.44
Onychoblastoma (hamartoma of the nail unit): a new entity? Br J Dermatol (2005) 1.43
The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol (2000) 1.42
Geographical ancestry is a key determinant of epidermal morphology and dermal composition. Br J Dermatol (2014) 1.40
Congenital hypertrophy of the lateral nail folds of the hallux: clinical features and follow-up of seven cases. Pediatr Dermatol (2001) 1.40
Failure of topical estrogen receptor agonists and antagonists to alter murine hair follicle cycling. J Invest Dermatol (1998) 1.40
Providing lifestyle behaviour change support for patients with psoriasis: an assessment of the existing training competencies across medical and nursing health professionals. Br J Dermatol (2014) 1.39
The 'melanocyte-keratin' mystery revisited: neither normal human epidermal nor hair follicle melanocytes express keratin 16 or keratin 6 in situ. Br J Dermatol (2009) 1.39
Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol (2008) 1.39
The TGF-beta2 isoform is both a required and sufficient inducer of murine hair follicle morphogenesis. Dev Biol (1999) 1.38
The role of the hairless (hr) gene in the regulation of hair follicle catagen transformation. Am J Pathol (1999) 1.38
Thyroid function in systemic sclerosis. J Endocrinol Invest (1991) 1.38
Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived Neurotrophic functions. Am J Pathol (1999) 1.37
Making a 'point' about the safe disposal of sharps in patients on biological therapies. Br J Dermatol (2008) 1.37
Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur J Immunol (1998) 1.37
Alkaline phosphatase activity and localization during the murine hair cycle. Br J Dermatol (1994) 1.34
Molecular and functional aspects of the hairless (hr) gene in laboratory rodents and humans. Exp Dermatol (1998) 1.33
A new classification of onychomycosis. Br J Dermatol (1998) 1.33
Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis? J Immunol (2000) 1.29
Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis. Anticancer Res (1999) 1.29
Active hair growth (anagen) is associated with angiogenesis. J Invest Dermatol (2000) 1.29
Melanogenesis during the anagen-catagen-telogen transformation of the murine hair cycle. J Invest Dermatol (1994) 1.27
Periungual and subungual pyogenic granuloma. Br J Dermatol (2010) 1.27
A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol (2002) 1.27
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up. Br J Dermatol (2013) 1.26
Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling. FASEB J (2000) 1.26
Senile hair graying: H2O2-mediated oxidative stress affects human hair color by blunting methionine sulfoxide repair. FASEB J (2009) 1.25
Management of alopecia areata. BMJ (2010) 1.25
Differential expression and activity of melanogenesis-related proteins during induced hair growth in mice. J Invest Dermatol (1991) 1.24
Contact dermatitis in hairdressers: the Italian experience. Gruppo Italiano Ricerca Dermatiti da Contatto e Ambientali. Contact Dermatitis (1992) 1.24
High-dose fluconazole therapy for cryptococcal meningitis in patients with AIDS. Clin Infect Dis (1996) 1.24
Recognition of need in health care consultations: a qualitative study of people with psoriasis. Br J Dermatol (2012) 1.23
E- and P-cadherin expression during murine hair follicle morphogenesis and cycling. Exp Dermatol (1999) 1.22
Characterization of functional vanilloid receptors expressed by mast cells. Blood (1998) 1.21
Retracted The IL-15R alpha chain signals through association with Syk in human B cells. J Immunol (2001) 1.20
Hair cycle-dependent plasticity of skin and hair follicle innervation in normal murine skin. J Comp Neurol (1997) 1.20
Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?". Ann N Y Acad Sci (1999) 1.18
Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle. Br J Dermatol (1994) 1.18
Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol (2003) 1.17
Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. Am J Pathol (1997) 1.17
Hair casts are a dermoscopic clue for the diagnosis of traction alopecia. Br J Dermatol (2010) 1.17
What causes alopecia areata? Exp Dermatol (2013) 1.14
Adherence to medication in patients with psoriasis: a systematic literature review. Br J Dermatol (2013) 1.14
Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis (2007) 1.13
Differential contribution of CDKAL1 variants to psoriasis, Crohn's disease and type II diabetes. Genes Immun (2009) 1.12
The role of neuropeptides in psoriasis. Br J Dermatol (2006) 1.12
Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. Br J Dermatol (2005) 1.11
The BCL11AXL transcription factor: its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells. Leukemia (2006) 1.11
Adherence to treatment in patients with psoriasis. J Eur Acad Dermatol Venereol (2006) 1.11
Inpatient management of psoriasis: a multicentre service review to establish national admission standards. Br J Dermatol (2007) 1.10
The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life. J Am Acad Dermatol (1999) 1.09
Natural killer and natural killer-T cells in psoriasis. Arch Dermatol Res (2002) 1.09
Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia. Gut (1997) 1.09
Brittle nails. J Cosmet Dermatol (2004) 1.09
Interventions for chronic palmoplantar pustulosis. Cochrane Database Syst Rev (2006) 1.09
Striae gravidarum in primiparae. Br J Dermatol (2006) 1.08
Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum. J Am Acad Dermatol (1996) 1.08
Contact dermatitis in hairdressers' clients. Contact Dermatitis (1992) 1.08
Celiac disease and alopecia areata: report of a new association. Gastroenterology (1995) 1.06
Towards defining the pathogenesis of the hairless phenotype. J Invest Dermatol (1998) 1.06
Metastatic carcinoma to the terminal phalanx of the big toe: report of two cases and review of the literature. J Am Acad Dermatol (1994) 1.05